175 related articles for article (PubMed ID: 20877300)
21. A genome-wide association study of a sustained pattern of antidepressant response.
Hunter AM; Leuchter AF; Power RA; Muthén B; McGrath PJ; Lewis CM; Cook IA; Garriock HA; McGuffin P; Uher R; Hamilton SP
J Psychiatr Res; 2013 Sep; 47(9):1157-65. PubMed ID: 23726668
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D.
Adkins DE; Clark SL; Åberg K; Hettema JM; Bukszár J; McClay JL; Souza RP; van den Oord EJ
Transl Psychiatry; 2012 Jul; 2(7):e129. PubMed ID: 22760553
[TBL] [Abstract][Full Text] [Related]
23. Genetics of emergent suicidality during antidepressive treatment--data from a naturalistic study on a large sample of inpatients with a major depressive episode.
Musil R; Zill P; Seemüller F; Bondy B; Meyer S; Spellmann I; Bender W; Adli M; Heuser I; Fisher R; Gaebel W; Maier W; Rietschel M; Rujescu D; Schennach R; Möller HJ; Riedel M
Eur Neuropsychopharmacol; 2013 Jul; 23(7):663-74. PubMed ID: 23063133
[TBL] [Abstract][Full Text] [Related]
24. Body weight as a predictor of antidepressant efficacy in the GENDEP project.
Uher R; Mors O; Hauser J; Rietschel M; Maier W; Kozel D; Henigsberg N; Souery D; Placentino A; Perroud N; Dernovsek MZ; Strohmaier J; Larsen ER; Zobel A; Leszczynska-Rodziewicz A; Kalember P; Pedrini L; Linotte S; Gunasinghe C; Aitchison KJ; McGuffin P; Farmer A
J Affect Disord; 2009 Nov; 118(1-3):147-54. PubMed ID: 19269691
[TBL] [Abstract][Full Text] [Related]
25. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
[TBL] [Abstract][Full Text] [Related]
26. Genetic predictors of antidepressant side effects: a grouped candidate gene approach in the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Hodgson K; Uher R; Crawford AA; Lewis G; O'Donovan MC; Keers R; Dernovsek MZ; Mors O; Hauser J; Souery D; Maier W; Henigsberg N; Rietschel M; Placentino A; Aitchison K; Farmer A; Davis O; McGuffin P
J Psychopharmacol; 2014 Feb; 28(2):142-50. PubMed ID: 24414086
[TBL] [Abstract][Full Text] [Related]
27. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Mundt C; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Henkel V; Möller HJ
Int J Neuropsychopharmacol; 2009 Mar; 12(2):181-9. PubMed ID: 18662490
[TBL] [Abstract][Full Text] [Related]
28. Multimarker analysis suggests the involvement of BDNF signaling and microRNA biosynthesis in suicidal behavior.
Pulay AJ; Réthelyi JM
Am J Med Genet B Neuropsychiatr Genet; 2016 Sep; 171(6):763-76. PubMed ID: 26921221
[TBL] [Abstract][Full Text] [Related]
29. History of suicide attempts among patients with depression in the GENDEP project.
Perroud N; Uher R; Hauser J; Rietschel M; Henigsberg N; Placentino A; Kozel D; Maier W; Mors O; Souery D; Dmitrzak-Weglarz M; Jorgensen L; Kovacic Z; Giovannini C; Mendlewicz J; Zobel A; Strohmaier J; McGuffin P; Aitchison KJ; Farmer A
J Affect Disord; 2010 Jun; 123(1-3):131-7. PubMed ID: 19772940
[TBL] [Abstract][Full Text] [Related]
30. Do suicidal thoughts or behaviors recur during a second antidepressant treatment trial?
Perlis RH; Uher R; Perroud N; Fava M
J Clin Psychiatry; 2012 Nov; 73(11):1439-42. PubMed ID: 23059018
[TBL] [Abstract][Full Text] [Related]
31. BDNF promoter methylation and suicidal behavior in depressive patients.
Kang HJ; Kim JM; Lee JY; Kim SY; Bae KY; Kim SW; Shin IS; Kim HR; Shin MG; Yoon JS
J Affect Disord; 2013 Nov; 151(2):679-685. PubMed ID: 23992681
[TBL] [Abstract][Full Text] [Related]
32. Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.
Ballard ED; Luckenbaugh DA; Richards EM; Walls TL; Brutsché NE; Ameli R; Niciu MJ; Vande Voort JL; Zarate CA
J Psychiatr Res; 2015 Sep; 68():68-73. PubMed ID: 26228403
[TBL] [Abstract][Full Text] [Related]
33. Early and delayed onset of response to antidepressants in individual trajectories of change during treatment of major depression: a secondary analysis of data from the Genome-Based Therapeutic Drugs for Depression (GENDEP) study.
Uher R; Mors O; Rietschel M; Rajewska-Rager A; Petrovic A; Zobel A; Henigsberg N; Mendlewicz J; Aitchison KJ; Farmer A; McGuffin P
J Clin Psychiatry; 2011 Nov; 72(11):1478-84. PubMed ID: 22127194
[TBL] [Abstract][Full Text] [Related]
34. Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants.
Malki K; Uher R; Paya-Cano J; Binder E; Rietschel M; Zobel A; Mors O; Hauser J; Henigsberg N; Jerman B; Souery D; Placentino A; Ng MY; Cohen-Woods S; Sluyter F; Farmer A; Aitchison KJ; Craig IW; Lewis CM; McGuffin P; Schalkwyk LC
Biol Psychiatry; 2011 Feb; 69(4):360-5. PubMed ID: 20970119
[TBL] [Abstract][Full Text] [Related]
35. Transcriptomics and the mechanisms of antidepressant efficacy.
Hodgson K; Tansey KE; Powell TR; Coppola G; Uher R; Zvezdana Dernovšek M; Mors O; Hauser J; Souery D; Maier W; Henigsberg N; Rietschel M; Placentino A; Aitchison KJ; Craig IW; Farmer AE; Breen G; McGuffin P; Dobson R
Eur Neuropsychopharmacol; 2016 Jan; 26(1):105-112. PubMed ID: 26621261
[TBL] [Abstract][Full Text] [Related]
36. A genomewide association study of citalopram response in major depressive disorder.
Garriock HA; Kraft JB; Shyn SI; Peters EJ; Yokoyama JS; Jenkins GD; Reinalda MS; Slager SL; McGrath PJ; Hamilton SP
Biol Psychiatry; 2010 Jan; 67(2):133-8. PubMed ID: 19846067
[TBL] [Abstract][Full Text] [Related]
37. Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder.
DiazGranados N; Ibrahim LA; Brutsche NE; Ameli R; Henter ID; Luckenbaugh DA; Machado-Vieira R; Zarate CA
J Clin Psychiatry; 2010 Dec; 71(12):1605-11. PubMed ID: 20673547
[TBL] [Abstract][Full Text] [Related]
38. The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
De La Garza N; Rush AJ; Killian MO; Grannemann BD; Carmody TJ; Trivedi MH
Depress Anxiety; 2019 Apr; 36(4):313-320. PubMed ID: 30370613
[TBL] [Abstract][Full Text] [Related]
39. Polygenic associations of neurodevelopmental genes in suicide attempt.
Sokolowski M; Wasserman J; Wasserman D
Mol Psychiatry; 2016 Oct; 21(10):1381-90. PubMed ID: 26666204
[TBL] [Abstract][Full Text] [Related]
40. Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I).
Fu DJ; Ionescu DF; Li X; Lane R; Lim P; Sanacora G; Hough D; Manji H; Drevets WC; Canuso CM
J Clin Psychiatry; 2020 May; 81(3):. PubMed ID: 32412700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
